Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Shee

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast CancerWei Yang, Sarah R Hosford, Lloye M Dillon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2020
AMPK Activation by Metformin Promotes Survival of Dormant ER<sup>+</sup> Breast Cancer CellsRiley A Hampsch, Jason D Wells, Nicole A Traphagen, et al.
Breast Cancer Research and Treatment|December 11, 2014
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancerJennifer R Bean, Sarah R Hosford, Lynn K Symonds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.
Breast Cancer Research and Treatment|June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancerMary D Chamberlin, Jason D Wells, Kevin Shee, et al.
The Journal of Biological Chemistry|February 1, 2018
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53Esha Madan, Taylor M Parker, Matthias R Bauer, et al.
Journal of Endourology|March 24, 2023
The Fate of Residual Fragments After Percutaneous Nephrolithotomy: Results from the Endourologic Disease Group for Excellence Research ConsortiumVictor K F Wong, Jessica Que, Emily K Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast CancerWei Yang, Sarah R Hosford, Lloye M Dillon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2020
AMPK Activation by Metformin Promotes Survival of Dormant ER<sup>+</sup> Breast Cancer CellsRiley A Hampsch, Jason D Wells, Nicole A Traphagen, et al.
Breast Cancer Research and Treatment|December 11, 2014
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancerJennifer R Bean, Sarah R Hosford, Lynn K Symonds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.
Breast Cancer Research and Treatment|June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancerMary D Chamberlin, Jason D Wells, Kevin Shee, et al.
The Journal of Biological Chemistry|February 1, 2018
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53Esha Madan, Taylor M Parker, Matthias R Bauer, et al.
Journal of Endourology|March 24, 2023
The Fate of Residual Fragments After Percutaneous Nephrolithotomy: Results from the Endourologic Disease Group for Excellence Research ConsortiumVictor K F Wong, Jessica Que, Emily K Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Pageof 7